| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |